This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Cramer's Action Alerts PLUS - See his portfolio and get alerts BEFORE every trade. Learn more NOW!

Fish & Richardson Principal Jonathan E. Singer Named Minnesota Lawyer 2012 "Attorney Of Year" And Law360 "2012 MVP"

MINNEAPOLIS, Jan. 29, 2013 /PRNewswire/ -- Fish & Richardson today announced that Jonathan E. Singer, head of the firm's Life Sciences Practice, has been named Minnesota Lawyer's 2012 "Attorney of the Year" – a designation he has won three times in the past five years.  Earlier this month, Singer was recognized by Law360 as a "2012 Appellate Most Valuable Player."  Singer will receive his Minnesota Lawyer award on February 21, 2013.

The "Attorneys of the Year" awards are selected based on leadership in the profession and involvement in major cases.  The Law360 MVP awards honor attorneys whose accomplishments in major litigation or transactions have raised the bar in corporate law. 

In March 2012, Singer won a unanimous 9-0 decision at the U.S. Supreme Court for his long time client Mayo Clinic (Mayo Collaborative Servs. v. Prometheus Labs) in their eight-year patent litigation with Prometheus Laboratories.  The Court ruled in Mayo Clinic's favor that Prometheus' two broad drug monitoring patents were invalid and not patent eligible.

Singer's other major 2012 victories include winning a Federal Circuit ruling protecting Allergan's Alphagan P 0.1% glaucoma drug patent until 2022, which preserved over $1.5 billion in sales.  He also obtained a Federal Circuit precedential reversal of a district court decision that had invalidated his client Cephalon's Amrix patent claims, thereby preserving Amrix's $140 million annual market until the patents expire in 2024. 

Singer received his J.D., with honors, from the University of Chicago Law School (1992) and his A.B. in chemistry from Dartmouth College (1986).

Fish & Richardson is a global law firm providing strategic counseling and litigation services to innovative clients who seek to protect and maximize the value of their intellectual property (IP).  Founded in 1878, Fish's early clients included Alexander Graham Bell, Thomas Edison and the Wright Brothers.  The firm has more than 400 attorneys and technology specialists practicing IP strategy and counseling, IP litigation, and commercial litigation.  Fish is consistently singled out for its superior technical expertise and great results, and has been named the top patent litigation firm in the country for nine consecutive years, the number one IP firm for America's biggest companies, and an elite top tier law practice.  For more information, visit  www.fr.com or follow @fishrichardson on Twitter.

SOURCE Fish & Richardson

Copyright 2011 PR Newswire. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Try it NOW
Only $9.95
Try it NOW
14-Days Free
Try it NOW

Check Out Our Best Services for Investors

Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
Try it NOW
Try it NOW
Try it NOW
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
SYM TRADE IT LAST %CHG

Markets

DOW 18,098.76 -104.61 -0.57%
S&P 500 2,099.21 -8.57 -0.41%
NASDAQ 4,969.4420 -10.4590 -0.21%

Partners Compare Online Brokers

Free Reports

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs